AAPL   398.94 (+3.98%)
MSFT   215.26 (+0.74%)
FB   249.10 (+1.64%)
GOOGL   1,568.13 (+1.89%)
AMZN   3,330.83 (+4.09%)
NVDA   428.88 (+2.32%)
BABA   260.73 (-0.11%)
GE   6.70 (+0.15%)
TSLA   1,762.05 (+14.07%)
AMD   56.99 (+1.99%)
ACB   12.28 (+2.16%)
GILD   77.47 (+1.51%)
DIS   119.59 (+0.20%)
NFLX   568.40 (+3.58%)
BAC   23.97 (-0.21%)
BA   175.39 (-1.71%)
AAPL   398.94 (+3.98%)
MSFT   215.26 (+0.74%)
FB   249.10 (+1.64%)
GOOGL   1,568.13 (+1.89%)
AMZN   3,330.83 (+4.09%)
NVDA   428.88 (+2.32%)
BABA   260.73 (-0.11%)
GE   6.70 (+0.15%)
TSLA   1,762.05 (+14.07%)
AMD   56.99 (+1.99%)
ACB   12.28 (+2.16%)
GILD   77.47 (+1.51%)
DIS   119.59 (+0.20%)
NFLX   568.40 (+3.58%)
BAC   23.97 (-0.21%)
BA   175.39 (-1.71%)
AAPL   398.94 (+3.98%)
MSFT   215.26 (+0.74%)
FB   249.10 (+1.64%)
GOOGL   1,568.13 (+1.89%)
AMZN   3,330.83 (+4.09%)
NVDA   428.88 (+2.32%)
BABA   260.73 (-0.11%)
GE   6.70 (+0.15%)
TSLA   1,762.05 (+14.07%)
AMD   56.99 (+1.99%)
ACB   12.28 (+2.16%)
GILD   77.47 (+1.51%)
DIS   119.59 (+0.20%)
NFLX   568.40 (+3.58%)
BAC   23.97 (-0.21%)
BA   175.39 (-1.71%)
AAPL   398.94 (+3.98%)
MSFT   215.26 (+0.74%)
FB   249.10 (+1.64%)
GOOGL   1,568.13 (+1.89%)
AMZN   3,330.83 (+4.09%)
NVDA   428.88 (+2.32%)
BABA   260.73 (-0.11%)
GE   6.70 (+0.15%)
TSLA   1,762.05 (+14.07%)
AMD   56.99 (+1.99%)
ACB   12.28 (+2.16%)
GILD   77.47 (+1.51%)
DIS   119.59 (+0.20%)
NFLX   568.40 (+3.58%)
BAC   23.97 (-0.21%)
BA   175.39 (-1.71%)
Log in

NYSEARCA:PBEInvesco Dynamic Biotechnology & Genome ETF Stock Price, Forecast & News

$60.39
+0.45 (+0.75 %)
(As of 07/13/2020 10:47 AM ET)
Add
Today's Range
$60.34
Now: $60.39
$60.53
50-Day Range
$53.13
MA: $57.40
$60.83
52-Week Range
$38.08
Now: $60.39
$61.23
Volume585 shs
Average Volume11,706 shs
Market Capitalization$247.60 million
P/E RatioN/A
Dividend Yield0.05%
BetaN/A
PowerShares Dynamic Biotechnology & Genome Portfolio (the Fund) is based on the Dynamic Biotechnology & Genome Intellidex Index (the Index). The Fund seeks investment results that correspond generally to the price and yield of the Index. The Index consists of stocks of 30 the United States biotechnology and genome companies. The Fund will normally invest at least 90% of its total assets in common stocks that consists of the Index. The Index is designed to provide capital appreciation by evaluating companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. Invesco PowerShares Capital Management LLC acts as the Fund's investment adviser.
Read More

Geographic Exposure of PBE

Currency Exposure of PBE

Sector Exposure of PBE

Industry Exposure of PBE


Basic Details

Issuer Invesco
Fund NameInvesco Dynamic Biotechnology & Genome ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:PBE
Inception Date6/23/2005
Fund ManagerPeter Hubbard, Michael Jeanette, Tony Seisser, Jonathan Nixon
Phone+1-800-9830903

Fund Focus

Asset ClassEquity
BenchmarkDynamic Biotechnology & Genome Intellidex Index
CategorySector
FocusHealth Care
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$245.69 million
Average Daily Volume$7,763.10
Discount/Premium0.02%

ETF Expenses

Management Fee0.50%
Other Expenses0.08%
Total Expenses0.58%
Fee Waiver0.00%
Net Expenses0.58%

Administrator, Advisor and Custodian

AdministratorThe Bank of New York Mellon Corporation
AdvisorInvesco Capital Management LLC
CustodianThe Bank of New York Mellon Corporation
DistributorInvesco Distributors, Inc.
Transfer AgentThe Bank of New York Mellon Corporation
Trustee
Lead Market MakerCitadel

Receive PBE News and Ratings via Email

Sign-up to receive the latest news and ratings for PBE and its competitors with MarketBeat's FREE daily newsletter.

Invesco Dynamic Biotechnology & Genome ETF (NYSEARCA:PBE) Frequently Asked Questions

How has Invesco Dynamic Biotechnology & Genome ETF's stock been impacted by COVID-19 (Coronavirus)?

Invesco Dynamic Biotechnology & Genome ETF's stock was trading at $45.90 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, PBE shares have increased by 31.6% and is now trading at $60.39. View which stocks have been most impacted by Coronavirus.

Has Invesco Dynamic Biotechnology & Genome ETF been receiving favorable news coverage?

Press coverage about PBE stock has trended very negative recently, InfoTrie Sentiment reports. The research group identifies positive and negative press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Invesco Dynamic Biotechnology & Genome ETF earned a news impact score of -3.2 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the next several days. View the latest news about Invesco Dynamic Biotechnology & Genome ETF.

What other stocks do shareholders of Invesco Dynamic Biotechnology & Genome ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Invesco Dynamic Biotechnology & Genome ETF investors own include Align Technology (ALGN), Activision Blizzard (ATVI), Netflix (NFLX), Boeing (BA), Mastercard (MA), Micron Technology (MU), NVIDIA (NVDA), Paypal (PYPL), Visa (V) and Wayfair (W).

Who are Invesco Dynamic Biotechnology & Genome ETF's key executives?

Invesco Dynamic Biotechnology & Genome ETF's management team includes the following people:
  • H. Bruce Bond, Chairman of the Board of Trustee, Chief Executive Officer
  • Bruce T. Duncan, Chief Financial Officer, Treasurer
  • Kevin R. Gustafson, Chief Compliance Officer
  • Keith A Ovitt, Secretary
  • Ronn R. Bagge, Trustee
  • Marc M Kole, Trustee
  • D. Mark McMillan, Trustee
  • Philip M. Nussbaum Mba, Trustee
  • Donald H. Wilson, Trustee

What is Invesco Dynamic Biotechnology & Genome ETF's stock symbol?

Invesco Dynamic Biotechnology & Genome ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "PBE."

Who are Invesco Dynamic Biotechnology & Genome ETF's major shareholders?

Invesco Dynamic Biotechnology & Genome ETF's stock is owned by many different retail and institutional investors. Top institutional investors include Joseph P. Lucia & Associates LLC (0.02%).

Which major investors are selling Invesco Dynamic Biotechnology & Genome ETF stock?

PBE stock was sold by a variety of institutional investors in the last quarter, including Joseph P. Lucia & Associates LLC.

How do I buy shares of Invesco Dynamic Biotechnology & Genome ETF?

Shares of PBE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Invesco Dynamic Biotechnology & Genome ETF's stock price today?

One share of PBE stock can currently be purchased for approximately $60.39.

How big of a company is Invesco Dynamic Biotechnology & Genome ETF?

Invesco Dynamic Biotechnology & Genome ETF has a market capitalization of $247.60 million.

What is Invesco Dynamic Biotechnology & Genome ETF's official website?

The official website for Invesco Dynamic Biotechnology & Genome ETF is www.invescopowershares.com.

How can I contact Invesco Dynamic Biotechnology & Genome ETF?

Invesco Dynamic Biotechnology & Genome ETF's mailing address is 301 West Roosevelt Road, WHEATON, IL 60187, United States. The company can be reached via phone at +1-800-9830903.

This page was last updated on 7/13/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.